Weight Loss Programs

Semaglutide and tirzepatide are FDA-approved medications that help with weight loss and metabolic health by:
-Regulating appetite, making you feel fuller faster.
-Improving blood sugar control by increasing insulin secretion.
-Encouraging the body to use stored fat for energy.
These medications are commonly found in treatments like Wegovy, Ozempic, and Mounjaro.

-Semaglutide (Wegovy, Ozempic): Works by mimicking GLP-1 to regulate appetite and blood sugar.
-Tirzepatide (Mounjaro): Works on both GLP-1 and GIP, offering dual action for enhanced fat metabolism and blood sugar control.

-Reduced appetite and cravings.
-Improved blood sugar levels.
-Increased fat breakdown for steady, sustainable weight loss.

-Fewer side effects like nausea and digestive discomfort.
-Allows the body to adjust for better tolerability.
-Supports gradual metabolic improvements.

Most side effects are mild and improve over time, including:
-Common: Nausea, diarrhea, constipation, fatigue, reduced appetite.
-Less common: Upset stomach, mild headaches, dizziness.
-Rare but serious: Gallbladder issues, pancreatitis, gastroparesis.

-Week 1: Reduced appetite and cravings.
-8-12 Weeks: Visible weight loss when combined with a healthy lifestyle.
-6-12 Months: Continued steady weight loss with consistent use

-Semaglutide: Starts at 0.25 mg per week, increasing to a maintenance dose of 2.4 mg.
-Tirzepatide: Starts at 2.5 mg per week, increasing to a target dose of 10-15 mg.

-Sometimes combined with diet and exercise plans for better results.
-May be used with other weight loss medications under medical supervision.
-Should not be combined with similar GLP-1 medications.

-Compounded versions are often more affordable.
-May include additional ingredients like B12 or niacinamide.

Methionine: Helps break down fat and detoxify the liver.
Inositol: Supports fat metabolism and insulin sensitivity.
Choline: Reduces fat storage and improves liver function.
Vitamin B12: Boosts energy and metabolism.

-Easier adjustment for appetite and digestion changes.
-More cost-effective while still providing great results.
-Builds a strong foundation before transitioning to tirzepatide for enhanced fat metabolism.

-For Diabetes: Ozempic and Mounjaro are often covered.
-For Weight Loss: Wegovy may be covered for obesity, but Mounjaro is not yet FDA-approved for weight loss.
Savings programs may be available through manufacturers.

Protein first: Keeps you full and preserves muscle.
Fiber next: Supports digestion and controls cravings.
Carbs last: Provides balanced energy without spikes.

Semaglutide: 15-16% of initial body weight.
Tirzepatide: 14-18% reduction in body weight.

-Stomach (abdomen): Best for easy access and absorption.
-Upper arm: Another effective injection site.
-Rotate sites to avoid irritation.